Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1472-6882

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat ; volume:19 ; number:1 ; day:9 ; month:8 ; year:2019 ; pages:1-12 ; date:12.2019
BMC complementary and alternative medicine ; 19, Heft 1 (9.8.2019), 1-12, 12.2019

Creator: Lee, Ka-Yeon
Kim, Jae-Hyun
Kim, Eun-Young
Yeom, Mijung
Jung, Hyuk-Sang
Sohn, Youngjoo

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12906-019-2611-8

URN: urn:nbn:de:101:1-2019122921574735749339

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lee, Ka-Yeon
Kim, Jae-Hyun
Kim, Eun-Young
Yeom, Mijung
Jung, Hyuk-Sang
Sohn, Youngjoo
SpringerLink (Online service)

Other Objects (12)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells

Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis

Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1

Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells

Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis

Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1

Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells

Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis

Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1

Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells

Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis

Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1

Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells

Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis

Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1

Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells

Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis

Disulfiram ameliorates bone loss in ovariectomized mice by suppressing osteoclastogenesis

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1

Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB

Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL

The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor

RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling

Related objects

Reset password